141 results on '"Dierlamm, Judith"'
Search Results
2. EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma
3. Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape
4. NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
5. Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group
6. T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
7. Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy
8. Non-Random Pattern of Integration for Epstein-Barr Virus with Preference for Gene-Poor Genomic Chromosomal Regions into the Genome of Burkitt Lymphoma Cell Lines
9. Essential Role of MALT1 Protease Activity in Activated B Cell-Like Diffuse Large B-Cell Lymphoma
10. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group
11. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma
12. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group
13. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
14. Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
15. The novel cryptic translocation t(12;17)(p13;p12) involves the ETV6 and the PER1 genes
16. ider(14)(q10)t(8;14)(q24;q32) represents a novel chromosomal abnormality in Burkittʼs type acute lymphoblastic leukemia
17. T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma
18. ALL of Burkitt's type (L3) showing a Complex Karyotype including translocations t(14;18) (q32;q21) and t(3;8) (q27;q24) with BCL2 and BCL6 involvement.
19. Dic (19;21) (p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome positive ALL.
20. Comparative genomic hybridization and interphase fluorescence in situ hybridization reveals a low prevalence of chromosomal imbalances in hairy cell leukemia.
21. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung
22. Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
23. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML
24. Efficient Transformation of Primary Human Mesenchymal Stromal Cells by Adenovirus Early Region 1 Oncogenes
25. Radiation and Dose‐densification of R‐CHOP in Aggressive B‐cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
26. Forced Activation of β-Catenin Signaling Supports the Transformation of hTERT-Immortalized Human Fetal Hepatocytes
27. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL–positive CML cells
28. Incidence of ETV6 Cryptic Translocations In Myeloid Disorders
29. Chromosomes 2q, 4q and 13q21 Are Preferential Targets of Epstein-Barr Virus (EBV) Integration In Burkitt's Lymphoma Cell Lines
30. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung
31. Response: The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not
32. Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas
33. No Adverse Impact of 13q14 and P53 Deletion, t(4;14)(p16;q32) or Overrepresentation of CMYC(8q24) as Detected by Fluorescence In Situ Hybridization on Outcome in Patients with Multiple Myeloma Following Dose-Reduced Allogeneic Stem Cell Transplantation.
34. Functional and Antigenic Detection of Intravascular Tissue Factor (TF).
35. Characterization of Bcr-Abl Positive Leukemic Cells under Long-Term In Vitro Treatment with Telomerase Inhibitor BIBR1532.
36. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
37. Deletion of p53 as Detected by Fluorescence In Situ Hybridization Is Associated with Significant Shorter Event-Free Survival in Patients with Multiple Myeloma Who Are Receiving Allogeneic Blood Stem Cell Transplantation.
38. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLTspecific probes
39. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication ofHelicobacter pylori infection
40. The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
41. Fluorescence In Situ Hybridization Characterization of New Translocations Involving TEL (ETV6) in a Wide Spectrum of Hematologic Malignancies
42. Establishment and characterization of a newhuman pancreatic adenocarcinoma cell line withhigh metastatic potential to the lung.
43. Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice.
44. The t(14;18)(q32;q21)/IGH-MALT1translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma
45. T(14;18)(q32;q21) involving IGHandMALT1is a frequent chromosomal aberration in MALT lymphoma
46. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2and MLTspecific probes
47. The Apoptosis Inhibitor Gene API2and a Novel 18q Gene,MLT,Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas
48. PET-guided Treatment in Patients with Advanced-stage Hodgkin's Lymphoma (HD18): Final Results of An Open-label, International, Randomised Phase 3 Trial by the German Hodgkin Study Group.
49. Incidence of ETV6Cryptic Translocations In Myeloid Disorders
50. Molecular Characterization of the T(14;18)(q32;q21) Involving the IGHLocus and the MALT1Gene in MALT Lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.